FDA Approves Tremfya for Active Crohn Disease in Adults
Tremfya is the first and only interleukin-23 inhibitor offering both subcutaneous and intravenous induction options for Crohn ...
Healthline4d
Do You Need to Treat Asymptomatic Crohn’s Disease?
Silent Crohn’s disease may have little or no symptoms. It's important to monitor disease activity and treat the condition to ...
Medscape5d
FDA OKs Guselkumab for Crohn’s Disease
Guselkumab is the first and only interleukin-23 inhibitor that offers both subcutaneous and intravenous induction options for ...
FDA approves Tremfya for active Crohn's disease in adults
The U.S. Food and Drug Administration has approved Johnson & Johnson's Tremfya (guselkumab) for adult patients with ...
PHL1715h
Take Steps towards cures for IBD with the Crohn’s & Colitis Foundation on May 9th
Take Steps is the Crohn’s & Colitis Foundation’s signature fundraising event. This year (2025), the event will take place at Citizen’s Bank Park on May 9th. Funds raised at Take Steps ...
Rheumatology Advisor2d
Tremfya Approved for Moderately to Severely Active Crohn Disease
The FDA has approved Tremfya (guselkumab) for the treatment of adults with moderately to severely active Crohn disease.
Explore more
Healio5d
Extended treatment with Skyrizi ‘may ultimately benefit’ refractory Crohn’s disease
Patients with moderate to severe Crohn’s disease who did not achieve clinical response to IV induction with Skyrizi ...
The Canadian Press on MSN5d
AI can predict premature death among people with inflammatory bowel disease: study
A new study suggests AI can predict premature death among people who have inflammatory bowel disease, also known as Crohn's ...
Rolling Out3d
The food factor in managing inflammatory bowel disease
Studies show how some plant foods can reduce inflammation, prevent flare-ups and even lower surgery risks for those with ...
Sportschosun on MSN3d
A drop of blood distinguishes Crohn's disease from ulcerative colitis...Laying the foundation for customized treatment of inflammatory bowel disease
Inflammatory bowel disease (IBD) is expected to be more accurate and personalized. Recently, Professor Lee Hong-seop's team ...